January 2016

The little girl’s epilepsy was so debilitating that she was virtually nonresponsive. Traditional antiseizure medicines could not reduce the five to 20 seizures she experienced daily when she first came to The Children’s Hospital of Philadelphia.

Imagine a trembling child in the Emergency Department (ED), with a parent about to collapse in tears while squeezing a tiny hand. A nurse notices the family’s rising distress and takes a few moments to talk with them about their fears and concerns, and to suggest specific ways to cope with the procedure that’s about to happen.

Mistakes happen. Inside every cell, the functions of life rely on the basic process of building proteins. But, about half the time, cells make errors when building proteins and have to recycle the pieces and start again.

An innovative new clinical trial launching this year at The Children’s Hospital of Philadelphia may not only help patients who have no further proven treatment options for neuroblastoma, a high-risk cancer, but may also be a model for how precision medicine clinical trials can spur better and faster cancer therapy discoveries in the fu

A first-of-its-kind open-access, data driven discovery platform that empowers new diagnostic tools and personalized, precision therapies for rare childhood diseases and pediatric cancers has been developed at The Children’s Hospital of Philadelphia.

While human milk feedings are important for all children, they can be a medical intervention that makes the difference between life and death for critically ill infants at The Children’s Hospital of Philadelphia.

Share This

Our monthly online news magazine Bench to Bedside explores the fascinating research developments, discoveries, and achievements by our remarkable scientists and physicians. In each issue, see how their endeavors have a powerful impact on children's well-being.